Related Experiment Video
Updated: Feb 7, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A
Abigail Katz1, Yvonne Nong2, Elaine J Ma3
1From the, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
None:
Background: Atopic dermatitis (AD) is linked to increased cardiovascular risk. While GLP-1 receptor agonists (GLP-1RAs) show cardiometabolic benefits in the general population, their impact in patients with AD remains unclear.Objective: To evaluate whether GLP-1RA use is associated with a reduced risk of major adverse cardiovascular events (MACE) in patients with AD.Methods: This retrospective cohort study used TriNetX Research Network. Patients with AD ≥12 years old who used GLP-1RAs between April 2005 and December 2020 were 1:1 propensity-score matched to patients with AD not on GLP-1RA by demographic and cardiovascular risk factors. The primary outcome was incidence of MACE (cerebrovascular disease [CVD], heart failure [HF], atherosclerosis, ischemic heart disease [IHD], and percutaneous coronary intervention [PCI]) at 5, 10, and 20 years post-index date.Results: Of the 547,246 patients with AD, 24,936 (4.6%) used GLP-1RAs. After propensity-matching, at 20 years, patients with AD on GLP-1RA had lower odds of CVD (adjusted odds ratio [aOR] 0.718 [0.643-0.800]), HF (aOR 0.791 [0.732-0.854]), atherosclerosis (aOR 0.768 [0.715-0.826]), and IHD (aOR 0.900 [0.841, 0.963]), compared with patients with AD not using GLP-1RAs.Conclusions: In patients with AD, GLP-1RA use was associated with a reduced long-term risk of CVD, HF, IHD, and atherosclerosis, highlighting their potential cardiometabolic benefit in this population.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Imaging Studies for Cardiovascular System V: CT
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

